Market Chatter: Mitsui to Build Asia-Wide Medical Data Network for Drug Trials

MT Newswires09-10

Mitsui & Co (TYO:8031) is establishing a medical data network across Asia to compile anonymized records from 1 million patients by 2028, Nikkei Asia reported on Thursday.

The move is aimed at assisting global pharmaceutical firms in clinical trial recruitment, the report said.

Working with Singapore-based startup Oncoshot and leveraging its hospital network stake, Mitsui has launched the platform with roughly 100,000 patient records across more than 20 facilities, Nikkei said.

The company is also in talks with major Japanese institutions to join by 2028, the report said.

Mitsui & Co did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2666556232?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-10 09:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2666556232","market":"hk","top_or_hot":-1,"title":"Market Chatter: Mitsui to Build Asia-Wide Medical Data Network for Drug Trials","media":"MT Newswires","content":"<html><body><p> <a href=\"https://laohu8.com/S/MITSF\">Mitsui &amp;</a>amp; Co (TYO:8031) is establishing a medical data network across Asia to compile anonymized records from 1 million patients by 2028, Nikkei Asia reported on Thursday.</p><p>The move is aimed at assisting global pharmaceutical firms in clinical trial recruitment, the report said.</p><p>Working with Singapore-based startup Oncoshot and leveraging its hospital network stake, Mitsui has launched the platform with roughly 100,000 patient records across more than 20 facilities, Nikkei said.</p><p>The company is also in talks with major Japanese institutions to join by 2028, the report said.</p><p><a href=\"https://laohu8.com/S/MITSY\">Mitsui &amp;</a>amp; Co did not immediately respond to MT Newswires' request for comment.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Chatter: Mitsui to Build Asia-Wide Medical Data Network for Drug Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Chatter: Mitsui to Build Asia-Wide Medical Data Network for Drug Trials\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time\">2026-09-10 09:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/MITSF\">Mitsui &amp;</a>amp; Co (TYO:8031) is establishing a medical data network across Asia to compile anonymized records from 1 million patients by 2028, Nikkei Asia reported on Thursday.</p><p>The move is aimed at assisting global pharmaceutical firms in clinical trial recruitment, the report said.</p><p>Working with Singapore-based startup Oncoshot and leveraging its hospital network stake, Mitsui has launched the platform with roughly 100,000 patient records across more than 20 facilities, Nikkei said.</p><p>The company is also in talks with major Japanese institutions to join by 2028, the report said.</p><p><a href=\"https://laohu8.com/S/MITSY\">Mitsui &amp;</a>amp; Co did not immediately respond to MT Newswires' request for comment.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2666556232","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2666556232","pubTimestamp":1789002204,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Mitsui & Co  is establishing a medical data network across Asia to compile anonymized records from 1 million patients by 2028, Nikkei Asia reported on Thursday.The move is aimed at assisting global pharmaceutical firms in clinical trial recruitment, the report said.Working with Singapore-based startup Oncoshot and leveraging its hospital network stake, Mitsui has launched the platform with roughly 100,000 patient records across more than 20 facilities, Nikkei said.The company is also in talks with major Japanese institutions to join by 2028, the report said.Mitsui & Co did not immediately respond to MT Newswires' request for comment.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"市场闲聊：三井物产将建立全亚洲医学数据网络用于药物试验","themeId":"b010cf239ffd4765bcd3edd8f767f746","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Mitsui &amp; Co (TYO:8031) is establishing a medical data network across Asia to compile anonymized records from 1 million patients by 2028, Nikkei Asia reported on Thursday.The move is aimed at assisting global pharmaceutical firms in clinical trial recruitment, the report said.Working with Singapore-based startup Oncoshot and leveraging its hospital network stake, Mitsui has launched the platform with roughly 100,000 patient records across more than 20 facilities, Nikkei said.The company is also in talks with major Japanese institutions to join by 2028, the report said.Mitsui &amp; Co did not immediately respond to MT Newswires' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)","kind":"news","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2666556232","isCrawlerRequest":true}